Publications
14
Citations
25
Est. group size
~3
Recurring co-author estimate
Active years
15
Publishing since 2011
John Hays' work focuses on cancer treatment research, particularly involving clinical trials for gastric and gastroesophageal junction cancers. The available record includes contributions to a large randomized, placebo-controlled phase III trial testing a chemotherapy combination in patients with advanced, previously-treated gastric cancer. Broader listed topics also touch on ovarian, hepatocellular, and genomic aspects of cancer, though these are not detailed by specific recent publications in the provided data.
Publication output was sparse or absent in the earlier part of the decade but has increased noticeably since 2023, suggesting a recent growth in research activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Table from Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
2023
- Supplementary Table from Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
2023
- Regular and Young Investigator Award Abstracts×2
- Gastroenterology Research×2
- Future Oncology×1
- JCI Insight×1
- Figshare×1
- Kai He
Medicine · The Ohio State University
- Parthib Das
Medicine · The Ohio State University
- Adam Khorasanchi
Medicine · The Ohio State University
- Na Zhuo
Medicine · Purdue University West Lafayette
- Hamzah Abu‐Sbeih
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile